These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11071883)

  • 21. The internal region leucine-rich repeat 6 of decorin interacts with low density lipoprotein receptor-related protein-1, modulates transforming growth factor (TGF)-β-dependent signaling, and inhibits TGF-β-dependent fibrotic response in skeletal muscles.
    Cabello-Verrugio C; Santander C; Cofré C; Acuña MJ; Melo F; Brandan E
    J Biol Chem; 2012 Feb; 287(9):6773-87. PubMed ID: 22203668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The extracellular matrix regulates the effect of decorin and transforming growth factor beta-2 (TGF-β2) on myoblast migration.
    Goetsch KP; Niesler CU
    Biochem Biophys Res Commun; 2016 Oct; 479(2):351-357. PubMed ID: 27644884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of decorin expression on transforming growth factor-beta-mediated collagen gel retraction and biglycan induction.
    Markmann A; Hausser H; Schönherr E; Kresse H
    Matrix Biol; 2000 Dec; 19(7):631-6. PubMed ID: 11102752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell adhesion to collagen and decreased myogenic gene expression implicated in the control of myogenesis by transforming growth factor beta.
    Heino J; Massagué J
    J Biol Chem; 1990 Jun; 265(18):10181-4. PubMed ID: 2162338
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth hormone and the insulin-like growth factor system in myogenesis.
    Florini JR; Ewton DZ; Coolican SA
    Endocr Rev; 1996 Oct; 17(5):481-517. PubMed ID: 8897022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Smad3-mediated transforming growth factor-beta1 signaling on satellite cell proliferation and differentiation in chickens.
    Li X; McFarland DC; Velleman SG
    Poult Sci; 2008 Sep; 87(9):1823-33. PubMed ID: 18753451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.
    Okamoto O; Fujiwara S; Abe M; Sato Y
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):537-41. PubMed ID: 9895299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of the myostatin/Smad signaling pathway by short decorin-derived peptides.
    El Shafey N; Guesnon M; Simon F; Deprez E; Cosette J; Stockholm D; Scherman D; Bigey P; Kichler A
    Exp Cell Res; 2016 Feb; 341(2):187-95. PubMed ID: 26844629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen.
    Schönherr E; Broszat M; Brandan E; Bruckner P; Kresse H
    Arch Biochem Biophys; 1998 Jul; 355(2):241-8. PubMed ID: 9675033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A kinase domain-truncated type I receptor blocks bone morphogenetic protein-2-induced signal transduction in C2C12 myoblasts.
    Namiki M; Akiyama S; Katagiri T; Suzuki A; Ueno N; Yamaji N; Rosen V; Wozney JM; Suda T
    J Biol Chem; 1997 Aug; 272(35):22046-52. PubMed ID: 9268344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of myogenic differentiation in myoblasts expressing a truncated type II TGF-beta receptor.
    Filvaroff EH; Ebner R; Derynck R
    Development; 1994 May; 120(5):1085-95. PubMed ID: 8026322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice.
    Casar JC; McKechnie BA; Fallon JR; Young MF; Brandan E
    Dev Biol; 2004 Apr; 268(2):358-71. PubMed ID: 15063173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-beta inhibition of insulin-like growth factor-binding protein-5 synthesis in skeletal muscle cells involves a c-Jun N-terminal kinase-dependent pathway.
    Rousse S; Lallemand F; Montarras D; Pinset C; Mazars A; Prunier C; Atfi A; Dubois C
    J Biol Chem; 2001 Dec; 276(50):46961-7. PubMed ID: 11598109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of decorin and biglycan by cultured osteoblastic cells.
    Takagi M; Yamada T; Kamiya N; Kumagai T; Yamaguchi A
    Histochem J; 1999 Jun; 31(6):403-9. PubMed ID: 10462226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulation of decorin and transforming growth factor-beta1 by decorin gene suppression in tendinocytes.
    Hosaka Y; Kirisawa R; Mafune N; Takehana K
    Connect Tissue Res; 2005; 46(1):18-26. PubMed ID: 16019410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.
    Hildebrand A; Romarís M; Rasmussen LM; Heinegård D; Twardzik DR; Border WA; Ruoslahti E
    Biochem J; 1994 Sep; 302 ( Pt 2)(Pt 2):527-34. PubMed ID: 8093006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
    Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
    Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decorin gene transfer-mediated suppression of TGF-beta synthesis abrogates experimental malignant glioma growth in vivo.
    Ständer M; Naumann U; Dumitrescu L; Heneka M; Löschmann P; Gulbins E; Dichgans J; Weller M
    Gene Ther; 1998 Sep; 5(9):1187-94. PubMed ID: 9930319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in secreted and cell associated proteoglycan synthesis during conversion of myoblasts to osteoblasts in response to bone morphogenetic protein-2: role of decorin in cell response to BMP-2.
    Gutierrez J; Osses N; Brandan E
    J Cell Physiol; 2006 Jan; 206(1):58-67. PubMed ID: 15920756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.